US Trade Representative Ron Kirk To Depart In February
United States Trade Representative Ron Kirk has announced his departure from office in late February.
Intellectual Property Watch
Original news and analysis on international IP policy
Category Patents/Designs/Trade Secrets
UNITAID Seeks Bids For ‘Freedom To Operate’ IPR Analyses For HIV Products
UNITAID, the drug purchasing facility affiliated with the World Health Organization, sees "great promise" in emerging diagnostic products for HIV treatment monitoring and diagnosis in remote regions. Now it is looking for someone to verify the freedom to operate of these tools, ensuring they are not intellectual property-encumbered.
2013: India Battles For Right To Use Compulsory Licences To Make Medicines Affordable
India has started the New Year on a volatile note. With general elections looming in 2014, there is turbulence and not just in the political world. In India’s pharmaceutical industry, there is sparring over the prickly issue of ‘compulsory licenses’, a mechanism by which a government allows a domestic company to manufacture and sell a generic version of a patented drug without the consent of the patent-holder, who receives compensation.
Packed WHO Executive Board Agenda Highlights Need To Streamline Priorities
World Health Organization Director General Margaret Chan today opened the 132nd meeting of the Executive Board, the UN agency’s highest authority, emphasising the importance of cost-effectiveness and results-driven operations at a time of global economic austerity and precarious funding.
US FTC Finds Sharp Rise In ‘Pay-For-Delay’ Deals Blocking Generics
The United States Federal Trade Commission, which keeps an eye out for anticompetitive behaviour, has issued a study finding that in 2012, a record number of deals were struck between brand-name and generic drug companies to keep the lower-priced generics off the market. Such deals, which arise from patent disputes, cost American consumers billions of dollars annually while piling on the federal deficit, it said.
EPO Sees Record Patent Filings, Grants
The European Patent Office has announced that it reached new records in 2012 for patent filings and patents granted, according to preliminary figures. The United States remained at top, but growth was fastest in Asia, while European filings remained stable, it said.
Official Offers Reflections On WHO Reform, Private Sector Role
In 2011, Margaret Chan, director general of the World Health Organization, launched a major reform of the United Nations organisation. This week, a presentation and discussions around the WHO reform by Gaudenz Silberschmidt, senior adviser in the WHO Office of the Director-General, highlighted the reason for this reform, its organisation and the possible impact the reform could have on the relationship between the pharmaceutical industry and the WHO.
Syngenta Opens Doors To Its Patented Technologies, For Easier But Not Free Access
A new innovation platform launched yesterday by Syngenta, the international agri-business company, means to broaden availability to some patented traits and technologies for vegetables, but also aims at opening new ways to use the intellectual property system.
US Senate Judiciary Committee 2013 Agenda Includes Privacy, Press Freedom
The United States Senate Judiciary Committee in 2013 will address topical issues of gun violence and immigration, but will also take up issues of citizens' civil liberties in light of ever-increasing security measures, and a push for government transparency, freedom of the press, digital rights, access to books for the visually impaired, and incentives for innovation.
Free Drugs Are “Crucial Part” Of Neglected Tropical Disease Fight
The World Health Organization reports that unprecedented progress has been made in addressing 17 parasitic diseases affecting the world’s poorest populations. The public health authority attributes the gains, in large part, to the contributions of global partners, including drug contributions made by research-based pharmaceutical giants.
Business’ Privileged Access To EU-India Trade Documents
The Corporate Europe Observatory and the European Commission presented their arguments in a case over access to documents about the EU-India free trade agreement before the General Court of the European Union in Luxembourg last Friday.
Company Takes A Fair Shot At Facebook, LinkedIn, With Social Networking Patents
A Virginia-based company in the midst of a multi-million dollar merger is asserting patents on fundamental aspects of social networking it says have been infringed by Facebook, LinkedIn and three other companies. But even if the patents have validity, they come at a time of what may be a backlash against such lawsuits.